Valuation Stryker Corporation CBOE
Stocks
0R2S
US8636671013
Medical Equipment, Supplies & Distribution
|
Real-time
CBOE
11:30:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 278.40 EUR | -0.57% |
|
-1.52% | - |
| 08-26 | Boston Scientific Says Cyberattack Disrupting Global Operations -- Update | DJ |
| 08-26 | Boston Scientific Says Cyberattack Disrupting Global Operations | DJ |
Company Valuation: Stryker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 100,882 | 92,522 | 113,776 | 137,257 | 134,410 | 126,844 | - | - |
| Change | - | -8.29% | 22.97% | 20.64% | -2.07% | -5.63% | - | - |
| Enterprise Value (EV) 1 | 110,335 | 102,451 | 121,655 | 144,952 | 146,258 | 135,969 | 132,732 | 129,355 |
| Change | - | -7.14% | 18.74% | 19.15% | 0.9% | -7.04% | -2.38% | -2.54% |
| P/E | 51.3x | 39.6x | 36.3x | 46.4x | 41.8x | 25.7x | 22.4x | 19.9x |
| PBR | 6.79x | 5.56x | 6.11x | 6.65x | 5.99x | 4.82x | 4.16x | 3.58x |
| PEG | - | 2.1x | 1.1x | -7.81x | 5.07x | 0.5x | 1.5x | 1.6x |
| Capitalization / Revenue | 5.9x | 5.02x | 5.55x | 6.07x | 5.35x | 4.65x | 4.27x | 3.97x |
| EV / Revenue | 6.45x | 5.55x | 5.93x | 6.42x | 5.82x | 4.98x | 4.47x | 4.04x |
| EV / EBITDA | 23.2x | 21.5x | 22.7x | 23.6x | 20.7x | 17.1x | 15.4x | 13.7x |
| EV / EBIT | 25.2x | 23.4x | 24.6x | 25.4x | 22.2x | 18.6x | 16.5x | 14.5x |
| EV / FCF | 40.3x | 50.3x | 39.2x | 41.6x | 34.1x | 35.2x | 26.4x | 22.2x |
| FCF Yield | 2.48% | 1.99% | 2.55% | 2.41% | 2.93% | 2.84% | 3.79% | 4.5% |
| Dividend per Share 2 | 2.585 | 2.835 | 3.05 | 3.24 | 3.4 | 3.6 | 3.832 | 4.118 |
| Rate of return | 0.97% | 1.16% | 1.02% | 0.9% | 0.97% | 1.09% | 1.16% | 1.25% |
| EPS 2 | 5.21 | 6.17 | 8.25 | 7.76 | 8.4 | 12.88 | 14.78 | 16.66 |
| Distribution rate | 49.6% | 45.9% | 37% | 41.8% | 40.5% | 28% | 25.9% | 24.7% |
| Net sales 1 | 17,108 | 18,449 | 20,498 | 22,595 | 25,116 | 27,295 | 29,675 | 31,990 |
| EBITDA 1 | 4,753 | 4,755 | 5,348 | 6,142 | 7,064 | 7,944 | 8,592 | 9,464 |
| EBIT 1 | 4,382 | 4,384 | 4,955 | 5,715 | 6,603 | 7,296 | 8,065 | 8,907 |
| Net income 1 | 1,994 | 2,358 | 3,165 | 2,993 | 3,246 | 4,942 | 5,746 | 6,398 |
| Net Debt 1 | 9,453 | 9,929 | 7,879 | 7,695 | 11,848 | 9,125 | 5,888 | 2,511 |
| Reference price 2 | 267.42 | 244.49 | 299.46 | 360.05 | 351.47 | 330.69 | 330.69 | 330.69 |
| Nbr of stocks (in thousands) | 377,240 | 378,430 | 379,938 | 381,216 | 382,424 | 383,573 | - | - |
| Announcement Date | 1/27/22 | 1/31/23 | 1/30/24 | 1/28/25 | 1/29/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 25.68x | 4.98x | 17.12x | 1.09% | 127B | ||
| 18.07x | 2.31x | 8.91x | 2.83% | 12.12B | ||
| -222.37x | 15.1x | 1792.36x | -.--% | 10.6B | ||
| 21.96x | 10.27x | 17.63x | 1.87% | 4.22B | ||
| 27.05x | - | - | - | 2.72B | ||
| -1425.52x | 1.68x | 7.88x | -.--% | 1.78B | ||
| 17.38x | 4.65x | 9.09x | 3.52% | 1.62B | ||
| Average | -219.68x | 6.50x | 308.83x | 1.55% | 22.84B | |
| Weighted average by Cap. | -7.62x | 5.56x | 136.08x | 1.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SYK Stock
- 0R2S Stock
- Valuation Stryker Corporation
Select your edition
All financial news and data tailored to specific country editions
















